Fig. 1. Serum levels of IGF-I vs Fig. 1. Serum levels of IGF-I vs. weeks of treatment during dose titration in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11):3913-3919. doi:10.1210/jcem.83.11.5223 J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
Fig. 2. Serum levels of IGFBP-3 vs Fig. 2. Serum levels of IGFBP-3 vs. weeks of treatment during dose titration in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11):3913-3919. doi:10.1210/jcem.83.11.5223 J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
Fig. 3. Serum levels of ALS vs Fig. 3. Serum levels of ALS vs. weeks of treatment during dose titration in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11):3913-3919. doi:10.1210/jcem.83.11.5223 J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
Fig. 4. Waist-to-hip ratio vs Fig. 4. Waist-to-hip ratio vs. months of treatment with rhGH in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11):3913-3919. doi:10.1210/jcem.83.11.5223 J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
Fig. 5. AGHDA score vs. months of treatment with rhGH in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11):3913-3919. doi:10.1210/jcem.83.11.5223 J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society